Who owns the SILVAKLENZ trademark?

The SILVAKLENZ trademark is owned by Molecular Therapeutics.

What class is the SILVAKLENZ trademark registered in?

The SILVAKLENZ trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for SILVAKLENZ?

The USPTO serial number for SILVAKLENZ is 87324050.

What is the registration number for SILVAKLENZ?

SILVAKLENZ is registered under USPTO registration number 5295081.

Sealvo

Home Search: SILVAKLENZSILVAKLENZ #87324050

Back

Updated Oct 14, 2026·22 searches this week

View on USPTO TSDR Find similar marks

SIL

USPTO Trademark Record

REGISTERED

SILVAKLENZ

SN 87324050·Reg 5295081·Filed Feb 03, 2017

Owner Molecular Therapeutics

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

SILVAKLENZ (Serial No. 87324050), Registration No. 5295081, is a registered US trademark filed on Feb 03, 2017 by Molecular Therapeutics. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

renewal 10y period: September 27, 2027347 days remaining

Mark Intelligence

SILVAKLENZ (Reg. #5295081) is a registered US trademark that has been protecting its owner, Molecular Therapeutics, since 2017. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Feb 03, 2017

SERIAL

87324050

REG#

5295081

REGISTERED

Sep 26, 2017

Filing Information

StatusREGISTERED

Filing DateFeb 03, 2017

Serial Number87324050

Registration No.5295081

Registration DateSep 26, 2017

Status DateMar 11, 2024

Published for OppositionJul 11, 2017

Filing Basis & Declarations

Standard Characters ClaimedFiled as Use ApplicationUse Application CurrentlySection 8 AcceptedSection 15 AcknowledgedTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

First use anywhere: Aug 08, 2005

First use in commerce: Aug 08, 2005

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

20 events

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Sep 26, 2026

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Mar 11, 2024

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

Mar 11, 2024

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Mar 11, 2024

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

TEAS SECTION 8 & 15 RECEIVED

Sep 18, 2023

TEAS SECTION 8 & 15 RECEIVED

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Sep 26, 2022

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

REGISTERED-PRINCIPAL REGISTER

Sep 26, 2017

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

Jul 11, 2017

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jul 11, 2017

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jun 21, 2017

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

May 27, 2017

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

May 26, 2017

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

May 25, 2017

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

May 25, 2017

CORRESPONDENCE RECEIVED IN LAW OFFICE

NON-FINAL ACTION WRITTEN

May 09, 2017

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

May 09, 2017

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

May 09, 2017

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Apr 28, 2017

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Feb 08, 2017

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Feb 07, 2017

NEW APPLICATION ENTERED

Other Marks by Molecular Therapeutics

Additional USPTO filings from the same owner.

TRI

TRICIDE

78267999

Molecular Therapeutics

REGISTERED

NEO

NEOCIDE-3

85273331

Molecular Therapeutics

REGISTERED

MOL

MOLECULAR THERAPEUTICS

87323951

Molecular Therapeutics

ABANDONED

TRI

TRICIDE-NEO

78264415

Molecular Therapeutics

ABANDONED

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Recently filed and registered marks in the same international class.

SIL

SILVAKLENZ

78688217

Medical Molecular Therapeutics

ABANDONED

Other Marks by Matthew T. Hoots

Additional USPTO filings handled by the same attorney of record.

TIF

TIF3D

99244496

REGISTERED

DRI

DRIBBLEUP

88817623

REGISTERED

TEM

TEMPTER IPA

88760603

REGISTERED

LEV

LEVEE & LOAM

98507920

REGISTERED

SILVAKLENZ

Run a conflict check

Other Marks by Molecular Therapeutics

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Matthew T. Hoots

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company